COSETTE PHARMACEUTICALS, INC.
- BRIDGEWATER, NJ 08807-2861
- cosettepharma.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $182.5K
- Awards on record
- 23
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
COSETTE PHARMACEUTICALS, INC. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About COSETTE PHARMACEUTICALS, INC.
- Headquarters
- BRIDGEWATER, NJ 08807-2861
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIHDQFPZ3SBV24
- CAGE8EQ02
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $182.5K
- Awards on record
- 23
- Top funding agencies
- Department of Veterans Affairs
Awards
36C26027F0018
Recompete 12–18 mo: Potential end Dec 19, 2027 (13 months away)BULK VYLEESI
Department of Veterans Affairs
- Obligated
- $34.7K
- Period of performance
- Dec 20, 2026 – Dec 19, 2027
36C26026F0104
Recompete < 6 mo: Potential end Dec 19, 2026 (1 month away)BREMELANOTIDE (VYLEESI) 1.75MG/0.3ML AUTOINJECTOR.
Department of Veterans Affairs
- Obligated
- $33.6K
- Period of performance
- Dec 20, 2025 – Dec 19, 2026
36C26026F0075
Recompete < 6 mo: Potential end Nov 30, 2026 (under a month away)BULK - VYLEESI 1.75MG/0.3ML AUTOINJECTOR
Department of Veterans Affairs
- Obligated
- $26.9K
- Period of performance
- Dec 1, 2025 – Nov 30, 2026
36C25027N0112
Completed: Period of performance ended Nov 12, 2026EMERGENCY VYLEESI DRUG INJECTORS
Department of Veterans Affairs
- Obligated
- $13.9K
- Period of performance
- Nov 2, 2026 – Nov 12, 2026
36C24527N0093
Completed: Period of performance ended Oct 9, 2026PATIENT MEDICATION FOR VYLEESI 1.75MG. THIS ORDER IS BEING PLACED FOR THE WASHINGTON DC VA MEDICAL CENTER.
Department of Veterans Affairs
- Obligated
- $16.6K
- Period of performance
- Oct 5, 2026 – Oct 9, 2026
36C25026F0668
Completed: Period of performance ended Sep 17, 2026BREMELANOTIDE 1.75MG/0.3ML AUTOINJECTOR VYLEESI
Department of Veterans Affairs
- Obligated
- $10.4K
- Period of performance
- Aug 18, 2026 – Sep 17, 2026
36C26026F0379
Completed: Period of performance ended Sep 12, 2026VYLEESI 1.75MG/0.3ML AUTOINJECTOR
Department of Veterans Affairs
- Obligated
- $3.5K
- Period of performance
- Aug 12, 2026 – Sep 12, 2026
36C24526N0726
Completed: Period of performance ended Jul 17, 2026VYLEESI .3 ML INJ
Department of Veterans Affairs
- Obligated
- $6.9K
- Period of performance
- Jul 10, 2026 – Jul 17, 2026
36C25926P0526
Completed: Period of performance ended Jul 12, 2026EMERGENT PHARMA BUY SPRIX SPRAY
Department of Veterans Affairs
- Obligated
- $1.1K
- Period of performance
- Jun 12, 2026 – Jul 12, 2026
36C25926P0553
Completed: Period of performance ended Jul 7, 2026PHARMACY SPRIX SPRAY
Department of Veterans Affairs
- Obligated
- $3.4K
- Period of performance
- Jun 30, 2026 – Jul 7, 2026
36C24526N0685
Completed: Period of performance ended Jun 30, 2026VYLEESI .3 ML INJ
Department of Veterans Affairs
- Obligated
- $6.9K
- Period of performance
- Jun 26, 2026 – Jun 30, 2026
36C25026N0571
Completed: Period of performance ended Jun 17, 2026VYLEESI
Department of Veterans Affairs
- Obligated
- $6.9K
- Period of performance
- May 19, 2026 – Jun 17, 2026
36C26026F0242
Completed: Period of performance ended May 27, 2026VYLEESI 1.75MG/0.3ML AUTOINJECTOR
Department of Veterans Affairs
- Obligated
- $3.5K
- Period of performance
- Apr 27, 2026 – May 27, 2026
36C26026F0217
Completed: Period of performance ended Apr 16, 2026VYLEESI
Department of Veterans Affairs
- Obligated
- $4.2K
- Period of performance
- Mar 16, 2026 – Apr 16, 2026
36C25926F0127
Completed: Period of performance ended Apr 3, 2026PHARMACY
Department of Veterans Affairs
- Obligated
- $3.5K
- Period of performance
- Mar 3, 2026 – Apr 3, 2026
36C24126F0078
Completed: Period of performance ended Mar 30, 2026VYLEESI (BREMELANOTIDE) 1.75MG/0.3ML AUTOINJECTOR BOXES OF 4
Department of Veterans Affairs
- Obligated
- $14.6K
- Period of performance
- Feb 26, 2026 – Mar 30, 2026
36C25226F0127
Completed: Period of performance ended Feb 12, 2026BREMELANOTIDE 1.75MG/0.3ML AUTOINJECTOR. NDC: 00713-0897-04.
Department of Veterans Affairs
- Obligated
- $2.1K
- Period of performance
- Feb 2, 2026 – Feb 12, 2026
36C24526N0246
Completed: Period of performance ended Jan 21, 2026VYLEESI .3 ML INJ
Department of Veterans Affairs
- Obligated
- $3.5K
- Period of performance
- Jan 15, 2026 – Jan 21, 2026
36C25926F0087
Completed: Period of performance ended Jan 20, 2026MICRO-PURCHASE VYLEESI PRESCRIBED FOR VETERAN CARE
Department of Veterans Affairs
- Obligated
- $3.5K
- Period of performance
- Jan 14, 2026 – Jan 20, 2026
36C26025F0180
Completed: Period of performance ended Nov 30, 2025VYLEESI 1.75MG/0.3ML AUTOINJECTOR
Department of Veterans Affairs
- Obligated
- $8.1K
- Period of performance
- Jun 1, 2025 – Nov 30, 2025
36C26025F0174
Completed: Period of performance ended Jun 30, 2025BREMELANOTIDE 1.75MG/0.3ML (VYLEESI)
Department of Veterans Affairs
- Obligated
- $2.7K
- Period of performance
- Mar 7, 2025 – Jun 30, 2025
36C26025F0239
Completed: Period of performance ended Jun 29, 2025VYLEESI 1.75MG/0.3ML AUTOINJECTOR
Department of Veterans Affairs
- Obligated
- $3.4K
- Period of performance
- Apr 29, 2025 – Jun 29, 2025
36C26125F0300
Completed: Period of performance ended Jun 14, 2025BREMELANOTIDE (VYLEESI) 1.75MG/0.3ML AUTOINJECTOR
Department of Veterans Affairs
- Obligated
- $3.4K
- Period of performance
- May 14, 2025 – Jun 14, 2025
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
36C26027F0018 under 36F79720D0191 BULK VYLEESI | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $34.7K | Dec 20, 2026 – Dec 19, 2027 | Recompete 12–18 mo: Potential end Dec 19, 2027 (13 months away)AI brief for award 36C26027F0018Bid team for the recompete of award 36C26027F0018 |
36C26026F0104 under 36F79720D0191 BREMELANOTIDE (VYLEESI) 1.75MG/0.3ML AUTOINJECTOR. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $33.6K | Dec 20, 2025 – Dec 19, 2026 | Recompete < 6 mo: Potential end Dec 19, 2026 (1 month away)AI brief for award 36C26026F0104Bid team for the recompete of award 36C26026F0104 |
36C26026F0075 under 36F79720D0191 BULK - VYLEESI 1.75MG/0.3ML AUTOINJECTOR | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $26.9K | Dec 1, 2025 – Nov 30, 2026 | Recompete < 6 mo: Potential end Nov 30, 2026 (under a month away)AI brief for award 36C26026F0075Bid team for the recompete of award 36C26026F0075 |
36C25027N0112 under 36F79720D0191 EMERGENCY VYLEESI DRUG INJECTORS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $13.9K | Nov 2, 2026 – Nov 12, 2026 | Completed: Period of performance ended Nov 12, 2026 |
36C24527N0093 under 36F79720D0191 PATIENT MEDICATION FOR VYLEESI 1.75MG. THIS ORDER IS BEING PLACED FOR THE WASHINGTON DC VA MEDICAL CENTER. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $16.6K | Oct 5, 2026 – Oct 9, 2026 | Completed: Period of performance ended Oct 9, 2026 |
36C25026F0668 under 36F79720D0191 BREMELANOTIDE 1.75MG/0.3ML AUTOINJECTOR VYLEESI | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $10.4K | Aug 18, 2026 – Sep 17, 2026 | Completed: Period of performance ended Sep 17, 2026 |
36C26026F0379 under 36F79720D0191 VYLEESI 1.75MG/0.3ML AUTOINJECTOR | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $3.5K | Aug 12, 2026 – Sep 12, 2026 | Completed: Period of performance ended Sep 12, 2026 |
36C24526N0726 under 36F79720D0191 VYLEESI .3 ML INJ | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $6.9K | Jul 10, 2026 – Jul 17, 2026 | Completed: Period of performance ended Jul 17, 2026 |
36C25926P0526 EMERGENT PHARMA BUY SPRIX SPRAY | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $1.1K | Jun 12, 2026 – Jul 12, 2026 | Completed: Period of performance ended Jul 12, 2026 |
36C25926P0553 PHARMACY SPRIX SPRAY | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $3.4K | Jun 30, 2026 – Jul 7, 2026 | Completed: Period of performance ended Jul 7, 2026 |
36C24526N0685 under 36F79720D0191 VYLEESI .3 ML INJ | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $6.9K | Jun 26, 2026 – Jun 30, 2026 | Completed: Period of performance ended Jun 30, 2026 |
36C25026N0571 under 36F79720D0191 VYLEESI | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $6.9K | May 19, 2026 – Jun 17, 2026 | Completed: Period of performance ended Jun 17, 2026 |
36C26026F0242 under 36F79720D0191 VYLEESI 1.75MG/0.3ML AUTOINJECTOR | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $3.5K | Apr 27, 2026 – May 27, 2026 | Completed: Period of performance ended May 27, 2026 |
36C26026F0217 under 36F79720D0191 VYLEESI | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $4.2K | Mar 16, 2026 – Apr 16, 2026 | Completed: Period of performance ended Apr 16, 2026 |
36C25926F0127 under 36F79720D0191 PHARMACY | Department of Veterans Affairs | 325412 · 3650CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $3.5K | Mar 3, 2026 – Apr 3, 2026 | Completed: Period of performance ended Apr 3, 2026 |
36C24126F0078 under 36F79720D0191 VYLEESI (BREMELANOTIDE) 1.75MG/0.3ML AUTOINJECTOR BOXES OF 4 | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $14.6K | Feb 26, 2026 – Mar 30, 2026 | Completed: Period of performance ended Mar 30, 2026 |
36C25226F0127 under 36F79720D0191 BREMELANOTIDE 1.75MG/0.3ML AUTOINJECTOR. NDC: 00713-0897-04. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $2.1K | Feb 2, 2026 – Feb 12, 2026 | Completed: Period of performance ended Feb 12, 2026 |
36C24526N0246 under 36F79720D0191 VYLEESI .3 ML INJ | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $3.5K | Jan 15, 2026 – Jan 21, 2026 | Completed: Period of performance ended Jan 21, 2026 |
36C25926F0087 under 36F79720D0191 MICRO-PURCHASE VYLEESI PRESCRIBED FOR VETERAN CARE | Department of Veterans Affairs | 325412 · 3650CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $3.5K | Jan 14, 2026 – Jan 20, 2026 | Completed: Period of performance ended Jan 20, 2026 |
36C26025F0180 under 36F79720D0191 VYLEESI 1.75MG/0.3ML AUTOINJECTOR | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $8.1K | Jun 1, 2025 – Nov 30, 2025 | Completed: Period of performance ended Nov 30, 2025 |
36C26025F0174 under 36F79720D0191 BREMELANOTIDE 1.75MG/0.3ML (VYLEESI) | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $2.7K | Mar 7, 2025 – Jun 30, 2025 | Completed: Period of performance ended Jun 30, 2025 |
36C26025F0239 under 36F79720D0191 VYLEESI 1.75MG/0.3ML AUTOINJECTOR | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $3.4K | Apr 29, 2025 – Jun 29, 2025 | Completed: Period of performance ended Jun 29, 2025 |
36C26125F0300 under 36F79720D0191 BREMELANOTIDE (VYLEESI) 1.75MG/0.3ML AUTOINJECTOR | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $3.4K | May 14, 2025 – Jun 14, 2025 | Completed: Period of performance ended Jun 14, 2025 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325412Pharmaceutical Preparation ManufacturingPrimarySmall business under this code’s size standard
SAM.gov reports this entity as small under 1 of 1 NAICS code. Size is determined per code (SBA size standards).
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with COSETTE PHARMACEUTICALS, INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.